This book provides a comprehensive overview of recent novel coronavirus (SARS-CoV-2) infection, their biology and associated challenges for their treatment and prevention of novel Coronavirus Disease 2019 (COVID-19). Discussing various aspects of COVID-19 infection, including global epidemiology, genome organization, immunopathogenesis, transmission cycle, diagnosis, treatment, prevention, and control strategies, it highlights host-pathogen interactions, host immune response, and pathogen immune invasion strategies toward developing an immune intervention or preventive vaccine for COVID-19.
An understanding of the topics covered in the book is imperative in the context of designing strategies to protect the human race from further losses and harm due to SARS-CoV-2 infection causing COVID-19.
|
1 Current Insight into the Novel Coronavirus Disease 2019 (COVID-19) |
|
|
1 | (8) |
|
|
|
|
|
|
|
|
|
|
|
|
|
2 Global Trends in Epidemiology of Coronavirus Disease 2019 (COY II)- 19) |
|
|
9 | (14) |
|
|
|
|
|
|
|
|
|
3 Morphology, Genome Organization, Replication, and Pathogenesis of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) |
|
|
23 | (10) |
|
|
|
|
|
|
|
|
|
4 Transmission Cycle of SARS-CoV and SARS-CoV-2 |
|
|
33 | (10) |
|
|
|
|
|
5 Host Immune Response and Immunobiology of Human SARS-CoV-2 Infection |
|
|
43 | (12) |
|
|
|
|
|
|
|
|
|
6 Clinical Characteristics and Differential Clinical Diagnosis of Novel Coronavirus Disease 2019 (COVDD-19) |
|
|
55 | (16) |
|
|
|
|
|
|
|
|
|
|
|
7 Coronavirus Infection Among Children and Adolescents |
|
|
71 | (10) |
|
|
|
|
|
|
|
8 COVID-19: An Ophthalmological Update |
|
|
81 | (14) |
|
|
|
|
|
|
|
9 Laboratory Diagnosis of Novel Coronavirus Disease 2019 (COVID-19) Infection |
|
|
95 | (14) |
|
|
|
|
|
|
|
|
|
10 Therapeutic Development and Drugs for the Treatment ofCOVTO-19 |
|
|
109 | (18) |
|
|
|
|
|
|
|
|
|
11 Prevention and Control Strategies for SARS-CoV-2 Infection |
|
|
127 | (14) |
|
|
|
|
|
12 Classical Coronaviruses |
|
|
141 | (10) |
|
|
|
|
|
13 Emergence and Reemergence of Severe Acute Respiratory Syndrome (SARS) Coronaviruses |
|
|
151 | (14) |
|
|
|
|
|
14 Preparing for the Perpetual Challenges of Pandemics of Coronavirus Infections with Special Focus on SARS-CoV-2 |
|
|
165 | (22) |
|
|
|
|
|
15 Preparing Children for Pandemics |
|
|
187 | (12) |
|
|
|
|
|
16 Coping with Mental Health Challenges During COVID-19 |
|
|
199 | |
|
|
|
|
|
|
|
|
|
|
| Correction to: Transmission Cycle of SARS-CoV and SARS-CoV-2 |
|
1 | |
|
|
|
|
Prof. (Dr.) Shailendra K. Saxena is a Vice Dean and Professor at King George's Medical University, Lucknow. His primary research interest is to understand the molecular mechanisms of host defense during human viral infections and to develop predictive, preventive and therapeutic strategies against these diseases. Prof. Saxenas work has been published in various high impact factor reputed international journals. He has been honored by several prestigious National and International Awards, Fellowships and Scholarships in India and abroad, including Young Scientist Awards, BBSRC India Partnering Award and named as the Global Leader in Science by The Scientist magazine (USA) and International Opinion Leader/Expert that are involved in the vaccination for JE by IPIC (UK). He has been elected Fellow of The Royal Society of Biology UK (FRSB), The Royal Society of Chemistry UK (FRSC), The Academy of Environmental Biology, India (FAEB), Indian Virological Society (FIVS), The Biotech Research Society, India (FBRS); and Fellowship of the (European) Academy of Translational Medicine Professionals, Austria (FacadTM). He has been awarded Dr. JC Bose National Award of Department of Biotechnology (DBT, Min. of Science & Technology, Govt. of India) in Biotechnology and has an active collaboration with various US universities.
Daugiau apie elektronines knygas